Advertisement
Screener

Evome Medical Technologies, Inc. Operating Expenses

Evome Medical Technologies, Inc. Operating Expenses

Evome Medical Technologies, Inc. reported Operating Expenses of CAD 28.05 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-16.

Discontinued › Expense Statement › Operating Expenses

us-gaap:OperatingExpenses · last filed 2024-04-16

  • Evome Medical Technologies, Inc. operating expenses for the quarter ending 2023-12-31 was 6.86M CAD, a 69.92% increase year-over-year.
  • Evome Medical Technologies, Inc. operating expenses for the quarter ending 2023-09-30 was 8.28M CAD, a 112.31% increase year-over-year.
  • Evome Medical Technologies, Inc. operating expenses for the quarter ending 2023-06-30 was 8.12M CAD, a 128.44% increase year-over-year.
  • Evome Medical Technologies, Inc. operating expenses for the quarter ending 2023-03-31 was 4.79M CAD, a 62.76% increase year-over-year.
  • Evome Medical Technologies, Inc. operating expenses for fiscal 2023 was 28.05M CAD.
  • Evome Medical Technologies, Inc. operating expenses for fiscal 2022 was 6.57M CAD, a 563.45% increase from fiscal 2021.
  • Evome Medical Technologies, Inc. operating expenses for fiscal 2021 was 990.28K CAD.
Period endOperating Expenses 3 monthOperating Expenses 3 month as first filedOperating Expenses 6 monthOperating Expenses 9 monthOperating Expenses 10 monthOperating Expenses 12 monthOperating Expenses 12 month as first filed
2023-12-316.86M CAD
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16
15.14M CAD
derived: sum of 2 quarters · filed 2024-04-16
23.26M CAD
derived: sum of 3 quarters · filed 2024-04-16
28.05M CAD
10-K · filed 2024-04-16
2023-09-308.28M CAD
10-Q · filed 2023-11-14
16.41M CAD
derived: sum of 2 quarters · filed 2023-11-14
21.20M CAD
10-Q · filed 2023-11-14
2023-06-308.12M CAD
10-Q · filed 2023-08-14
12.91M CAD
10-Q · filed 2023-08-14
2023-03-314.79M CAD
10-Q · filed 2023-05-15
2022-12-3113.21M CAD
10-K · filed 2024-04-16
2022-11-304.04M CAD
10-Q · filed 2023-01-17
10.15M CAD
10-Q · filed 2023-01-17
2022-09-303.90M CAD
10-Q · filed 2023-11-14
10.40M CAD
10-Q · filed 2023-11-14
2022-08-313.34M CAD
10-Q · filed 2022-10-17
6.11M CAD
10-Q · filed 2022-10-17
2022-06-303.56M CAD
10-Q · filed 2023-08-14
6.50M CAD
10-Q · filed 2023-08-14
2022-05-312.88M CAD
10-Q · filed 2022-07-15
2022-03-312.94M CAD
10-Q · filed 2023-05-15
2022-02-283.32M CAD
derived: 10-KT 12 month − 10-Q 9 month · filed 2023-04-03
4.97M CAD
derived: sum of 2 quarters · filed 2023-04-03
6.07M CAD
derived: sum of 3 quarters · filed 2023-04-03
6.57M CAD
10-KT · filed 2023-04-03
5.73M CAD
10-K · filed 2022-05-31
2021-12-314.85M CAD
10-KT · filed 2023-04-03
2021-11-301.65M CAD
10-Q · filed 2023-01-17
2.76M CAD
derived: sum of 2 quarters · filed 2023-01-17
3.25M CAD
10-Q · filed 2023-01-17
3.42M CAD
derived: sum of 4 quarters · filed 2023-01-17
2021-08-311.10M CAD
10-Q · filed 2022-10-17
1.60M CAD
10-Q · filed 2022-10-17
1.77M CAD
derived: sum of 3 quarters · filed 2022-10-17
2.05M CAD
derived: sum of 4 quarters · filed 2022-10-17
2021-05-31497.78K CAD
10-Q · filed 2022-07-15
497.29K CAD
10-Q/A · filed 2021-08-02
664.31K CAD
derived: sum of 2 quarters · filed 2022-07-15
942.21K CAD
derived: sum of 3 quarters · filed 2022-07-15
1.30M CAD
derived: sum of 4 quarters · filed 2022-07-15
2021-02-28166.53K CAD
derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-31
444.43K CAD
derived: sum of 2 quarters · filed 2022-05-31
804.06K CAD
derived: sum of 3 quarters · filed 2022-05-31
990.28K CAD
10-K · filed 2022-05-31
2020-11-30277.90K CAD
10-Q · filed 2022-01-14
637.53K CAD
derived: sum of 2 quarters · filed 2022-01-14
823.75K CAD
10-Q · filed 2022-01-14
2020-08-31359.63K CAD
10-Q · filed 2021-10-15
545.85K CAD
10-Q · filed 2021-10-15
2020-05-31186.86K CAD
10-Q/A · filed 2021-08-02